NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000054402

Registered date:01/06/2024

Prospective observational study of patients with completely resected epidermal growth factor receptor mutation-positive non-small cell lung cancer (AURORA) (WJOG17023L)

Basic Information

Recruitment status Pending
Health condition(s) or Problem(s) studiednon-small cell lung cancer
Date of first enrollment2024/07/25
Target sample size650
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeDisease-free survival
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum18years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1) Pregnant women, lactating women, women who may be pregnant at the moment, or persons who have no intention of using birth control. 2) Patients with double cancer requiring treatment at the time of enrollment (however, carcinoma in situ and lesions equivalent to intramucosal carcinoma that are clinically or pathologically confirmed are not included in double cancer even if they are untreated.) 3) Patients with concurrent psychiatric disease or symptom that, in the opinion of the treating physician, would make it difficult for them to participate in the study. 4) Persons who are judged by the treating physician to be inappropriate for safe implementation of this study for any other reason.

Related Information

Contact

public contact
Name Naoki Ishizuka
Address Namba Plaza Bldg. 304-1-5-7, Motomachi Naniwa-ku, Osaka 556-0016 JAPAN Japan 556-0016
Telephone 06-6633-7400
E-mail datacenter@wjog.jp
Affiliation West Japan Oncology Group WJOG datacenter
scientific contact
Name Hirotsugu Kenmotsu
Address 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka 411-0934, Japan.
Telephone (+81)055-989-5222
E-mail h.kenmotsu@scchr.jp
Affiliation Shizuoka Cancer Center Division of Thoracic Oncology